Host: Charles Turck, PharmD, BCPS, BCCCP <br>

  Guest: Brian Mulherin, MD <br>


  
    <p>It's not uncommon for years to elapse after a patient first develops symptoms of paroxysmal nocturnal hemoglobinuria (PNH) and before a formal diagnosis is made. So how does the burden of PNH affect patient outcomes? Dive in as Dr. Charles Turck is joined by Dr. Brian Mulherin, Hematology and Oncology Specialist at Hematology Oncology of Indiana.</p>

Improving PNH Patient Outcomes

Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.